PUBLICATIONS · 33601323
Bromodomain and extra-terminal inhibitors-A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children-ACCELERATE.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Eur J Cancer
- Publication date
- 2021 Mar
- First author
- Pearson AD
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Pearson AD
- type
- Author
- name
- DuBois SG
- type
- Author
- name
- Buenger V
- type
- Author
- name
- Kieran M
- type
- Author
- name
- Stegmaier K
- type
- Author
- name
- Bandopadhayay P
- type
- Author
- name
- Bennett K
- type
- Author
- name
- Bourdeaut F
- type
- Author
- name
- Brown PA
- type
- Author
- name
- Chesler L
- type
- Author
- name
- Clymer J
- type
- Author
- name
- Fox E
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Pearson AD
- type
- Author
- name
- DuBois SG
- type
- Author
- name
- Buenger V
- type
- Author
- name
- Kieran M
- type
- Author
- name
- Stegmaier K
- type
- Author
- name
- Bandopadhayay P
- type
- Author
- name
- Bennett K
- type
- Author
- name
- Bourdeaut F
- type
- Author
- name
- Brown PA
- type
- Author
- name
- Chesler L
- type
- Author
- name
- Clymer J
- type
- Author
- name
- Fox E
- type
- Author
- bibliography ids
- nci-bib-88fe8e3c5bcffebe96c794bd
- book metadata
- content sha256
- af3a8b3ee0e34ee9a9e93f2f55a8cab263eb5f1801ad9405429741adcc717bec
- document type
- citation
- dois
- 10.1016/j.ejca.2021.01.018
- electronic publication date
- display
- 2021 Feb 16
- precision
- day
- year
- 2021
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:33601323
- immutable id
- pubmed:33601323@af3a8b3ee0e34ee9a9e93f2f55a8cab263eb5f1801ad9405429741adcc717bec
- journal
- abbreviation
- Eur J Cancer
- issn electronic
- 1879-0852
- issn print
- 0959-8049
- issue
- Source null
- name
- European journal of cancer (Oxford, England : 1990)
- nlm unique id
- 9005373
- pages
- 115-124
- volume
- 146
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 33601323
- provenance
- batch id
- 79f1021053e858d13ff3
- provider
- NCBI PubMed ESummary
- record sha256
- d1bac53f35b34790b7cd94daa5fc202f0ef6d848e83b1bc7942d4f7ea08223d1
- response sha256
- 671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
- retrieved at
- 2026-09-09T23:47:59.098265+00:00
- publication date
- display
- 2021 Mar
- precision
- month
- year
- 2021
- publication types
- Consensus Statement
- Journal Article
- Research Support, Non-U.S. Gov't
- Review
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Bromodomain and extra-terminal inhibitors-A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children-ACCELERATE.
Preserved source evidence · Not medical advice
Triangle